Goldman Sachs’s Adient ADNT Stock Holding History

Goldman Sachs’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35,700	Closed	-$1.58M	–	6170
2021 Q1	$1.58M	Buy	+35,700	New	+$1.35M	﹤0.01%	4226
2020 Q1	–	Sell	-76,300	Closed	-$1.62M	–	5186
2019 Q4	$1.62M	Buy	76,300 +38,100	+100%	+$845K	﹤0.01%	3786
2019 Q3	$877K	Buy	38,200 +1,500	+4%	+$34.2K	﹤0.01%	4113
2019 Q2	$891K	Buy	+36,700	New	+$755K	﹤0.01%	4066
2018 Q1	–	Sell	-147,144	Closed	-$11.6M	–	5864
2017 Q4	$11.6M	Sell	147,144 -12,100	-8%	-$976K	﹤0.01%	2353
2017 Q3	$13.4M	Buy	159,244 +141,899	+818%	+$10.1M	﹤0.01%	2313
2017 Q2	$1.13M	Sell	17,345 -638	-4%	-$43.4K	﹤0.01%	4344
2017 Q1	$1.31M	Buy	17,983 +14,441	+408%	+$949K	﹤0.01%	4144
2016 Q4	$208K	Buy	+3,542	New	+$187K	﹤0.01%	5744

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's ADNT Position: Q1 2026 in Review

Goldman Sachs increased its Adient (ADNT) stake by 36% in Q1 2026, buying an estimated $13M and bringing the position to 2,213,710 shares worth $44.7M. The position accounts for 0.01% of the portfolio, ranked #1671.

Goldman Sachs first reported a position in ADNT in Q4 2016 and has held it in 38 quarters since. The position peaked at $112M in Q2 2021. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

Goldman Sachs held 2,213,710 shares of Adient worth $44.7M as of Q1 2026.
Goldman Sachs bought 586,306 Adient shares in Q1 2026, an estimated $13M.
Adient made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1671 holding.
Goldman Sachs first reported a position in Adient in Q4 2016 and has held it in 38 quarters since.
Goldman Sachs's Adient position peaked at $112M in Q2 2021.
287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.